List of works - Alba Di Pardo

Assessment of Blood-brain Barrier Permeability by Intravenous Infusion of FITC-labeled Albumin in a Mouse Model of Neurodegenerative Disease.

scientific article

Beta-amyloid deposition in brain is enhanced in mouse models of arterial hypertension.

scientific article published on 27 July 2007

Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset

scientific article

Changes of peripheral TGF-β1 depend on monocytes-derived macrophages in Huntington disease

scientific article

DNA damage, homology-directed repair, and DNA methylation

scientific article published in July 2007

Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington's disease

scientific article

Disease-modifying effects of ganglioside GM1 in Huntington's disease models.

scientific article published on 9 October 2017

Enhanced expression of Harvey ras induced by serum deprivation in cultured astrocytes.

scientific article published on 12 April 2008

FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease.

scientific article published on 2 December 2013

Ganglioside GM1 induces phosphorylation of mutant huntingtin and restores normal motor behavior in Huntington disease mice

scientific article

Glyco-sphingo biology: a novel perspective for potential new treatments in Huntington's disease

scientific article published in September 2017

Impaired Levels of Gangliosides in the Corpus Callosum of Huntington Disease Animal Models

scientific article published on 6 October 2016

Impaired ganglioside metabolism in Huntington's disease and neuroprotective role of GM1.

scientific article published on March 2010

Impairment of blood-brain barrier is an early event in R6/2 mouse model of Huntington Disease

scientific article published on 24 January 2017

Liver specific inactivation of carboxylesterase 3/triacylglycerol hydrolase decreases blood lipids without causing severe steatosis in mice ⬇️

scientific article published on December 1, 2012

MRI measures of corpus callosum iron and myelin in early Huntington's disease.

scientific article published on 15 October 2013

Motor phenotype is not associated with vascular dysfunction in symptomatic Huntington's disease transgenic R6/2 (160 CAG) mice

scientific article published on 17 February 2017

Mutant Huntingtin induces activation of the Bcl-2/adenovirus E1B 19-kDa interacting protein (BNip3)

scientific article

Nebivolol induces nitric oxide release in the heart through inducible nitric oxide synthase activation.

scientific article published on 30 July 2007

Neuromedin U potentiates ADP- and epinephrine-induced human platelet activation

scientific article

Nitric oxide dysregulation in platelets from patients with advanced Huntington disease.

scientific article

Population stratification may bias analysis of PGC-1α as a modifier of age at Huntington disease motor onset

scientific article

Pressure-induced vascular oxidative stress is mediated through activation of integrin-linked kinase 1/betaPIX/Rac-1 pathway.

scientific article published on 21 September 2009

Pridopidine, a dopamine stabilizer, improves motor performance and shows neuroprotective effects in Huntington disease R6/2 mouse model

scientific article

Reduced bioavailable manganese causes striatal urea cycle pathology in Huntington's disease mouse model

scientific article published on 14 February 2017

Resistin impairs insulin-evoked vasodilation.

scientific article

Terapeutic Potential of Microencapsulated Sertoli Cells in Huntington Disease

scientific article published on 26 May 2016

The p85 regulatory subunit of PI3K mediates TSH-cAMP-PKA growth and survival signals

scientific article published on 09 October 2006

Tractography of the corpus callosum in Huntington's disease

scientific article

Tumor necrosis factor-alpha mediates hemolysis-induced vasoconstriction and the cerebral vasospasm evoked by subarachnoid hemorrhage.

scientific article published on 26 May 2009

β-amyloid inhibits protein prenylation and induces cholesterol sequestration by impairing SREBP-2 cleavage.

scientific article published in May 2012

List of works by Alba Di Pardo

Assessment of Blood-brain Barrier Permeability by Intravenous Infusion of FITC-labeled Albumin in a Mouse Model of Neurodegenerative Disease.

Beta-amyloid deposition in brain is enhanced in mouse models of arterial hypertension.

Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset

Changes of peripheral TGF-β1 depend on monocytes-derived macrophages in Huntington disease

DNA damage, homology-directed repair, and DNA methylation

Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington's disease

Disease-modifying effects of ganglioside GM1 in Huntington's disease models.

Enhanced expression of Harvey ras induced by serum deprivation in cultured astrocytes.

FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease.

Ganglioside GM1 induces phosphorylation of mutant huntingtin and restores normal motor behavior in Huntington disease mice

Glyco-sphingo biology: a novel perspective for potential new treatments in Huntington's disease

Impaired Levels of Gangliosides in the Corpus Callosum of Huntington Disease Animal Models

Impaired ganglioside metabolism in Huntington's disease and neuroprotective role of GM1.

Impairment of blood-brain barrier is an early event in R6/2 mouse model of Huntington Disease

Liver specific inactivation of carboxylesterase 3/triacylglycerol hydrolase decreases blood lipids without causing severe steatosis in mice ⬇️

MRI measures of corpus callosum iron and myelin in early Huntington's disease.

Motor phenotype is not associated with vascular dysfunction in symptomatic Huntington's disease transgenic R6/2 (160 CAG) mice

Mutant Huntingtin induces activation of the Bcl-2/adenovirus E1B 19-kDa interacting protein (BNip3)

Nebivolol induces nitric oxide release in the heart through inducible nitric oxide synthase activation.

Neuromedin U potentiates ADP- and epinephrine-induced human platelet activation

Nitric oxide dysregulation in platelets from patients with advanced Huntington disease.

Population stratification may bias analysis of PGC-1α as a modifier of age at Huntington disease motor onset

Pressure-induced vascular oxidative stress is mediated through activation of integrin-linked kinase 1/betaPIX/Rac-1 pathway.

Pridopidine, a dopamine stabilizer, improves motor performance and shows neuroprotective effects in Huntington disease R6/2 mouse model

Reduced bioavailable manganese causes striatal urea cycle pathology in Huntington's disease mouse model

Resistin impairs insulin-evoked vasodilation.

Terapeutic Potential of Microencapsulated Sertoli Cells in Huntington Disease

The p85 regulatory subunit of PI3K mediates TSH-cAMP-PKA growth and survival signals

Tractography of the corpus callosum in Huntington's disease

Tumor necrosis factor-alpha mediates hemolysis-induced vasoconstriction and the cerebral vasospasm evoked by subarachnoid hemorrhage.

β-amyloid inhibits protein prenylation and induces cholesterol sequestration by impairing SREBP-2 cleavage.